DCF Advisers »

Esperion Therapeutics shares owned by DCF Advisers

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by DCF Advisers from 13F filings

Historical chart of DCF Advisers investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by DCF Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by DCF Advisers

Quarter filed Position value Share count Share price at filing
2024-06-30 $555 250 2.22
2024-03-31 $9.4k 3.5k 2.68
2021-03-31 $485k 17k 28.06
2020-12-31 $1.0M 39k 26.00
2020-09-30 $2.1M 57k 37.17
2020-06-30 $2.5M 49k 51.32
2020-03-31 $694k 22k 31.55
2019-12-31 $894k 15k 59.60